# Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation

> **NCT03256942** · NA · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 75 (actual)

## Conditions studied

- Subjects Desiring Lip Augmentation

## Interventions

- **DEVICE:** Etermis 4®

## Key facts

- **NCT ID:** NCT03256942
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-16
- **Primary completion:** 2017-11-17
- **Final completion:** 2017-11-17
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03256942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03256942, "Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03256942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*